These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17509721)

  • 21. Temporary occlusion of two hepatic veins for chemoembolization of hepatocellular carcinoma with arteriohepatic vein shunts.
    Murata S; Tajima H; Abe Y; Fukunaga T; Nakazawa K; Mohamad RA; Kumazaki T
    AJR Am J Roentgenol; 2005 Feb; 184(2):415-7. PubMed ID: 15671355
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
    Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
    Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
    Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
    Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Economic impact of transarterial chemoembolization with drug eluting beads in the treatment of hepatocellular carcinoma].
    Malbranche C; Boulin M; Guiu B; Pernot C; Cercueil JP; Serge Aho L; Musat A; Bedenne L; Hillon P; Guignard MH; Fagnoni P
    Bull Cancer; 2011 Jun; 98(6):671-8. PubMed ID: 21642049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles.
    Padia SA; Shivaram G; Bastawrous S; Bhargava P; Vo NJ; Vaidya S; Valji K; Harris WP; Hippe DS; Kogut MJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):301-6. PubMed ID: 23380737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma.
    Vadot L; Boulin M; Guiu B; Aho LS; Vourc'h M; Musat A; Hillon P; Lepage C; Guignard MH; Fagnoni P
    J Clin Pharm Ther; 2015 Feb; 40(1):83-90. PubMed ID: 25413186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supraumbilical subcutaneous fat necrosis after transcatheter arterial chemoembolization with drug-eluting beads: case report and review of the literature.
    Kim HY; Bae SH; Park CH; Song MJ; Choi JY; Yoon SK; Jung ES; Chun HJ
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):276-9. PubMed ID: 22382809
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma: radiographic findings and clinical outcome.
    Suh SH; Won JY; Lee DY; Lee JT; Lee KH
    J Vasc Interv Radiol; 2005 Dec; 16(12):1741-5. PubMed ID: 16371544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
    Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
    J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma patients showing long-term complete responses to chemoembolization.
    Hashimoto T; Nakamura H; Tomoda K; Murakami T; Nakanishi K; Tsuda K; Ishida T; Kim T; Narumi Y
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-26-S6-28. PubMed ID: 9151913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Usefulness of nonattenuation corrected positron emission tomography image in a patient with hepatocarcinoma treated with chemoembolization].
    Orcajo Rincón J; Alonso Farto JC; Rotger Regi A; Zamudio Rodríguez D; Pérez Aradas V
    Rev Esp Med Nucl; 2010; 29(3):144-5. PubMed ID: 20398967
    [No Abstract]   [Full Text] [Related]  

  • 37. Meta-Analysis of Doxorubicin-Eluting Beads via Transcatheter Arterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma.
    Hui Y; Ruihua T; Jing L; Yaxiong L; Ji L; Linjie Y; Dongyan S; Mingliang J; Qingsheng H; Junling S
    Hepatogastroenterology; 2015 Jun; 62(140):1002-6. PubMed ID: 26902045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience.
    Higashihara H; Okazaki M
    Hepatogastroenterology; 2002; 49(43):72-8. PubMed ID: 11941988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.
    Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M
    AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.